Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway Roberto Cappai * ,† ,|| ,1 , Su-Ling Leck ‡ , Deborah J. Tew * ,|| , Nicholas A. Williamson § , David P. Smith * ,|| , Denise Galatis * ,|| , Robyn A. Sharples * ,‡ , Cyril C. Curtain * ,†† , Feda’ E. Ali * ,|| , Robert A. Cherny * ,|| , Janetta G. Culvenor * ,† ,|| , Stephen P. Bottomley ‡‡ , Colin L. Masters * ,|| , Kevin J. Barnham * ,|| and Andrew F. Hill * ,‡ * Department of Pathology, † Centre for Neuroscience, ‡ Department of Biochemistry and Molecular Biology, § Department of Microbiology and Immunology, The University of Melbourne, Victoria; and || The Mental Health Research Institute of Victoria, Parkville Victoria 3052; and †† School of Physics and Materials Engineering; and ‡‡ Department of Biochemistry and Molecular Biology, Monash University, Victoria, 3168, Australia 1 Correspondence: The University of Melbourne, Department of Pathology, Victoria, 3010, Australia. E-mail: r.cappai@unimelb.edu.au <h3>SPECIFIC AIMS</h3> The pathological hallmark of Parkinson’s disease (PD) is the loss of dopamine producing neurons in the substantia nigra and the formation of intraneuronal Lewy
/lp/fed-of-american-socs-for-experimental-biology/dopamine-promotes-synuclein-aggregation-into-sds-resistant-soluble-SE61svc4Lu